WeMen! Improving Women's Access to Healthcare System Through Men's Inclusion
WEMEN
1 other identifier
interventional
450
1 country
4
Brief Summary
Background: More than two-thirds of people living with HIV live in Sub-Saharan Africa, where the HIV prevalence in the adult population (aged 15-49) is 3.9%. In these countries a critical issue is represented by low level of adherence to treatment particularly in HIV positive pregnant women. Among the causes, the lack of male partner involvement represents a significant criticality. This issue emerge in Malawi, one of the countries with the highest prevalence of HIV in the world: 9.2% of the adult population living with HIV in 2018. Objective: to assess three different interventions aimed at improving adherence and retention to Anti Retroviral therapy among HIV positive women through engagement with their life partner in four Malawian healthcare centres. Methods: The prospective, controlled before-and-after study is articulated in three phases (total 24 months): pre-intervention, intervention and post-intervention analyses. The number of selected clinical centres is limited to four, one for each intervention plus a centre where no intervention will be performed (control arm). The interventions are 1) opening the facility on Saturday a month, only for men, defined "special day"; 2) peer-to-peer counselling among men, "male champions"; 3) providing incentive to all women accompanied by their partners at the facility, "nudge" (note1). The primary outcome of the study is the evaluation of the variations in retention in care and women's adherence to therapeutic protocols; the intermediate outcome is the assessment of the variations in Male Involvement (MI). The level of MI in the health of female partners (intermediate outcome) will be evaluated through a questionnaire administered at baseline and in the post-intervention phase. Data will be collected at the clinical centres and will be stored in two electronic databases. Results: Analysis of data collected in the four centres during the pre-intervention phase is on-going as the enrolment is stopped 31st March 2020. Total patients enrolled are 452 (133 Namandanje: 133, Kapeni: 78, Kapire: 75, Balaka: 166). Meantime, several meetings are performed in the centres to organize the intervention phase. Conclusions: The study will identified the better intervention to involve male partners in women's health according to an approach based on a broad spectrum of behaviours. \- Note1: the reason of the incentive is not reward the participation in the study but is the main activity of the intervention assessed. The intervention consist in giving an incentive. For this reason is not recommendable to eliminate this information as requested by the reviewer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Jul 2019
Typical duration for not_applicable hiv
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
April 10, 2020
CompletedFirst Posted
Study publicly available on registry
April 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2023
CompletedMay 20, 2021
May 1, 2021
1.8 years
April 10, 2020
May 17, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retention in care and adherence to treatment
Retention in care will be measured as the cumulative proportion of dropouts from the treatment program at 6 months, 1 year, and 2 years (excluding patients transferred to another centre or those who died). Adherence will be measured through the following indicators: (1) The cumulative proportion of medical appointments missed in a month period in the centre; (2) the cumulative proportion of appointments for drug delivery missed in a month period in the centre; (3) the cumulative proportion of women who suppressed viral load; (4) the cumulative proportion of women with a suppressed viral load that have a re-bound in viremia.
2 years
Secondary Outcomes (4)
Male Involvement - Proportion of women accompanied by partners
2 years
Male Involvement 2 - Proportion of men accepting HIV testing and counselling
2 years
Male Involvement 3 - Score scale of MI in health practices reported from female partners
2 years
Male Involvement 4 - Score scale of Gender Based Violence reported from female partner
2 years
Study Arms (4)
Special day
OTHERThe special day takes place with an extraordinary opening of the clinical centre once a month on a pre-festive day (Saturday). During this day, access will be reserved exclusively for men, including those who are not on treatment for HIV. The centre will offer free health promotion services to all participants.
Male Champions
OTHERThe "male champion" is a figure present in a few settings which carries out home visits with men and couples and follows up with men who did not accompany their partners to Antenatal Care visits. Usually, this role is covered by the female Expert Clients, namely HIV+ patients working in the organization as volunteers after appropriate training. Some men among patients who are on treatment will be identified and trained to cover this role.
Nudge
OTHERThe intervention based on the use of incentives (nudge) to men who follow the prevention and treatment program aims to evaluate whether this action is effective in guiding behaviour change towards the test, treatment, involvement and adherence to therapy approach.
No intervention
OTHERNo intervention will be carried out in a center.
Interventions
The study evaluates three different interventions aimed at improving adherence and retention to Anti Retroviral therapy among HIV positive women through engagement with their life partner. The interventions are 1) opening the facility once a month, only for men, "special day"; 2) testing peer-to-peer counselling among men, "male champions"; 3) providing incentive to all women accompanied by their partners at the facility, "nudge" or "incentive".
Eligibility Criteria
You may qualify if:
- Being HIV positive
- Age of 18 years or older
- Living at home with a male partner
You may not qualify if:
- No HIV positive
- No included in a HIV/AIDS prevention and treatment program
- Under 18 years old
- No partner living at home
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Rome Tor Vergatalead
- Scuola Superiore Sant'Anna di Pisacollaborator
- Comunità di S.Egidio ACAP Onluscollaborator
- Ministero degli Affari Esteri Italiacollaborator
Study Sites (4)
Balaka DREAM centre
Balaka, Malawi
Kapeni DREAM centre
Blantyre, Malawi
Namandanje DREAM centre
Machinga, Malawi
Kapire DREAM centre
Mangochi, Malawi
Related Publications (6)
Triulzi I, Palla I, Ciccacci F, Orlando S, Palombi L, Turchetti G. The effectiveness of interventions to involve men living with HIV positive pregnant women in low-income countries: a systematic review of the literature. BMC Health Serv Res. 2019 Dec 9;19(1):943. doi: 10.1186/s12913-019-4689-6.
PMID: 31815620BACKGROUNDAliyu MH, Sam-Agudu NA, Shenoi S, Goga AE, Ramraj T, Vermund SH, Audet CM. Increasing male engagement in the prevention of vertical transmission of HIV: what works in sub-Saharan Africa? BMJ. 2019 Jun 6;365:l1965. doi: 10.1136/bmj.l1965.
PMID: 31171558BACKGROUNDTakah NF, Kennedy ITR, Johnman C. The impact of approaches in improving male partner involvement in the prevention of mother-to-child transmission of HIV on the uptake of maternal antiretroviral therapy among HIV-seropositive pregnant women in sub-Saharan Africa: a systematic review and meta-analysis. BMJ Open. 2017 Nov 25;7(11):e018207. doi: 10.1136/bmjopen-2017-018207.
PMID: 29175889BACKGROUNDMancinelli S, Nielsen-Saines K, Germano P, Guidotti G, Buonomo E, Scarcella P, Lunghi R, Sangare H, Orlando S, Liotta G, Marazzi MC, Palombi L. Who will be lost? Identifying patients at risk of loss to follow-up in Malawi. The DREAM Program Experience. HIV Med. 2017 Sep;18(8):573-579. doi: 10.1111/hiv.12492. Epub 2017 Feb 2.
PMID: 28150466BACKGROUNDMatseke MG, Ruiter RAC, Rodriguez VJ, Peltzer K, Setswe G, Sifunda S. Factors Associated with Male Partner Involvement in Programs for the Prevention of Mother-to-Child Transmission of HIV in Rural South Africa. Int J Environ Res Public Health. 2017 Nov 1;14(11):1333. doi: 10.3390/ijerph14111333.
PMID: 29104275BACKGROUNDKaufman MR, Cornish F, Zimmerman RS, Johnson BT. Health behavior change models for HIV prevention and AIDS care: practical recommendations for a multi-level approach. J Acquir Immune Defic Syndr. 2014 Aug 15;66 Suppl 3(Suppl 3):S250-8. doi: 10.1097/QAI.0000000000000236.
PMID: 25007194BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Leonardo Palombi, MD, PhD
Università Tor Vergata Roma
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor
Study Record Dates
First Submitted
April 10, 2020
First Posted
April 22, 2020
Study Start
July 1, 2019
Primary Completion
April 30, 2021
Study Completion
January 30, 2023
Last Updated
May 20, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share